 |
Improving the IP Framework to Meet the Needs of Innovative IndustryTMPDF represents the views of UK industry in both IPR policy and practice matters within the EU, the UK and internationally. It believes that a cost effective, high quality IPR framework is a critical component in industry's present and future successes in the global economy. The policy papers on this website represent the views of the innovative and influential companies which are members of this well-established trade association. TMPDF members 2008:ARM Ltd; AstraZeneca plc; Babcock International Ltd; BAE Systems plc; BP p.l.c.; British Telecommunications plc; British-American Tobacco Co Ltd; BTG plc; Delphi Corp.; Dow Corning Ltd; Dyson Technology Ltd; ExxonMobil Chemical Ltd; Ford of Europe; Fujitsu Services Ltd; G E Healthcare; GKN plc; GlaxoSmithKline plc; Hewlett-Packard Ltd; IBM UK Ltd; Infineum UK Ltd; Kodak Ltd; Merck Sharp & Dohme Ltd; Microsoft Ltd; Nestle UK Ltd; Nokia UK Ltd; NXP Semiconductors UK Limited; Pfizer Ltd; Philips Electronics UK Ltd; Pilkington Group Ltd; Procter & Gamble Ltd; QinetiQ Ltd; Renishaw plc; Rohm and Haas (UK) Ltd; Rolls-Royce plc; Shell International Ltd; Sony UK Ltd; Syngenta Ltd; The BOC Group plc; UCB Pharma plc; Unilever plc; Wyeth Pharmaceuticals; Xerox Ltd.Influential and Respected: A History of SuccessThe Trade Marks Patents and Designs Federation was the first UK pan-industry intellectual property trade association established to represent member companies nationally and internationally. It was founded in 1920 in order to co-ordinate the views of industry and commerce in the United Kingdom, and to make representations to the appropriate authorities on policy and practice in intellectual property matters. Its input into both IP policy and practical IPR strategies continue in the 21st century, striving to ensure that governments and regulatory authorities in Europe and nationally meet the needs of industry. |